Early determination of renal allograft survival: a correlation between cytotoxic antibodies in recipient sera, renal pathology, and response to antirejection therapy.
D002986:Clinical Trials as Topic; D003602:Cytotoxicity, Immunologic; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D007668:Kidney / Q000473:pathology; D016030:Kidney Transplantation; D006435:Renal Dialysis; D014184:Transplantation, Homologous